On Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q3 2023 earnings per share (EPS) of $0.94, up 25.33% year over year. Total Bristol Myers Squibb Co earnings for the quarter were $1.93 billion. In the same quarter last year, Bristol Myers Squibb Co's earnings per share (EPS) was $0.75.
As of Q4 2023, Bristol Myers Squibb Co's earnings has grown 28.48% year over year. This is 17.97 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 10.51%. Bristol Myers Squibb Co's earnings in the past year totalled $8.29 billion.
What was BMY's revenue last quarter?
On Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q3 2023 revenue of $10.97 billion up 2.25% year over year. In the same quarter last year, Bristol Myers Squibb Co's revenue was $11.22 billion.
What was BMY's revenue growth in the past year?
As of Q4 2023, Bristol Myers Squibb Co's revenue has grown -3.86% year over year. This is 5.1 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 1.25%. Bristol Myers Squibb Co's revenue in the past year totalled $44.94 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.